Caribou Biosciences, Inc.
CRBUNASDAQHealthcare● Active
$1.68
+$0.08(+5.02%)
Market Cap$166127463
P/E Ratio—
52W High$3.535
52W Low$1.04
Caribou Biosciences, Inc. (CRBU) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CRBU · as of 2026-06-15
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $139.34M | $209.54M | $328.83M | $247.66M | $375.83M |
| Net Receivables | $2.98M | $3.25M | $3.86M | $4.66M | $8.12M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $145.23M | $219.38M | $338.84M | $260.25M | $391.19M |
| PP&E Net | $24.43M | $39.29M | $40.45M | $34.91M | $4.89M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $175.37M | $313.31M | $432.21M | $373.76M | $442.36M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.26M |
| Accounts Payable | $5.78M | $2.48M | $3.12M | $1.15M | $3.99M |
| Total Current Liabilities | $25.41M | $30.65M | $28.30M | $28.13M | $25.83M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $53.19M | $60.36M | $63.81M | $72.89M | $54.53M |
| Stockholders Equity | |||||
| Retained Earnings | ($596.51M) | ($448.39M) | ($299.29M) | ($197.22M) | ($97.79M) |
| Total Stockholders Equity | $122.17M | $252.95M | $368.40M | $300.87M | $387.82M |
| Total Liab & Equity(computed) | $175.37M | $313.31M | $432.21M | $373.76M | $442.36M |
| Debt Summary | |||||
| Total Debt | $27.23M | $26.49M | $27.11M | $27.75M | $0.26M |
| Net Debt | $14.87M | $10.19M | ($24.05M) | ($30.59M) | ($240.42M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · M
Explore more Caribou Biosciences, Inc. data
About Caribou Biosciences, Inc. (CRBU) Balance Sheet
Caribou Biosciences, Inc. (CRBU) balance sheet shows total assets of $0.18B with cash of $0.14B. Total liabilities are $0.05B, total debt $0.03B, and stockholders equity $0.12B.
Frequently asked questions
CRBU · 4 questionsCaribou Biosciences, Inc. has total debt of $0.03B with net debt of $0.01B.
CRBU total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15